z-logo
open-access-imgOpen Access
Protracted COVID-19 during Treatment of Facial Palsy
Author(s) -
Mehrdad Hasibi,
Maral Seyed Ahadi,
Hamed Abdollahi,
Mehrdad Jafari
Publication year - 2021
Publication title -
case reports in neurological medicine
Language(s) - English
Resource type - Journals
eISSN - 2090-6668
pISSN - 2090-6676
DOI - 10.1155/2021/5569841
Subject(s) - medicine , covid-19 , palsy , malaise , pandemic , bell's palsy , concomitant , pediatrics , bell palsy , surgery , disease , virology , pathology , alternative medicine , infectious disease (medical specialty) , outbreak
Neurologic manifestations are increasingly reported as the coronavirus disease 2019 (COVID-19) pandemic continues. This is a report of a COVID-19 patient with Bell's palsy. Case Summary. A 52-year-old man with fever and malaise was tested positive for COVID-19. After a week, he developed right-sided peripheral facial palsy and was treated with corticosteroids in conjunction with antiviral treatment which resulted in complete recovery. Discussion. Concomitant treatment of corticosteroids and antiviral treatment can decrease morbidity in patients with COVID-19-related Bell's palsy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom